A Study of the Safety, Tolerability and Effectiveness of Hydroxychloroquine and Itraconazole in Platinum-resistant Epithelial Ovarian Cancer

NCT03081702 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

13

Enrollment

OTHER

Sponsor class

Conditions

Platinum-resistant Epithelial Ovarian Cancer

Interventions

DRUG: Hydroxychloroquine
DRUG: Itraconazole

Sponsor

University Health Network, Toronto